BCL2L1 and pancreatic neoplasm: Xanthohumol dose-dependently decreased Bcl-xl levels and increased Bax levels in breast cancer cell lines (MCF-7) [50], pancreatic cancer cell lines (PANC-1) [34], and choliangiocarcinoma cell lines (M139 and M214) [51].